These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 20442857)

  • 21. Relationship of lipoprotein-associated phospholipase A₂ mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial.
    Ridker PM; MacFadyen JG; Wolfert RL; Koenig W
    Clin Chem; 2012 May; 58(5):877-86. PubMed ID: 22419750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males.
    Jang Y; Waterworth D; Lee JE; Song K; Kim S; Kim HS; Park KW; Cho HJ; Oh IY; Park JE; Lee BS; Ku HJ; Shin DJ; Lee JH; Jee SH; Han BG; Jang HY; Cho EY; Vallance P; Whittaker J; Cardon L; Mooser V
    PLoS One; 2011 Apr; 6(4):e18208. PubMed ID: 21490708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial variation in lipoprotein-associated phospholipase A₂ in older adults.
    Lee KK; Fortmann SP; Varady A; Fair JM; Go AS; Quertermous T; Hlatky MA; Iribarren C
    BMC Cardiovasc Disord; 2011 Jun; 11():38. PubMed ID: 21714927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
    Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoprotein-associated phospholipase A(2) and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: the Cardiovascular Health Study.
    Nelson TL; Kamineni A; Psaty B; Cushman M; Jenny NS; Hokanson J; Furberg C; Mukamal KJ
    Diabetologia; 2011 Feb; 54(2):329-33. PubMed ID: 21103980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of overweight and the PLA2G7 V279F polymorphism on the association of age with systolic blood pressure.
    Kim M; Kim M; Yoo HJ; Jang HY; Lee SH; Lee JH
    PLoS One; 2017; 12(3):e0173611. PubMed ID: 28334001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort.
    Persson M; Nilsson JA; Nelson JJ; Hedblad B; Berglund G
    Atherosclerosis; 2007 Feb; 190(2):388-96. PubMed ID: 16530769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of A379V variant of the Lp-PLA 2 gene on Lp-PLA 2 activity and markers of oxidative stress and endothelial function in Koreans.
    Chae JS; Kwak JH; Kim M; Shin KH; Lee SH; Jeong TS; Lee JH
    J Thromb Thrombolysis; 2014 Nov; 38(4):477-84. PubMed ID: 24682749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of lipoprotein-associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study.
    Brilakis ES; Khera A; Saeed B; Banerjee S; McGuire DK; Murphy SA; de Lemos JA
    Clin Chem; 2008 Dec; 54(12):1975-81. PubMed ID: 18832472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genome-wide association analysis of total cholesterol and high-density lipoprotein cholesterol levels using the Framingham heart study data.
    Ma L; Yang J; Runesha HB; Tanaka T; Ferrucci L; Bandinelli S; Da Y
    BMC Med Genet; 2010 Apr; 11():55. PubMed ID: 20370913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.
    Qi Y; Zhao D; Jia Z; Wang W; Wang M; Sun J; Liu J; Li Y; Xie W; Liu J
    Sci Rep; 2016 Dec; 6():37465. PubMed ID: 27905470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.
    Enkhmaa B; Anuurad E; Zhang W; Pearson TA; Berglund L
    Atherosclerosis; 2010 Aug; 211(2):526-30. PubMed ID: 20444451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease.
    Maiolino G; Lenzini L; Pedon L; Cesari M; Seccia TM; Frigo AC; Rossitto G; Caroccia B; Rossi GP
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):29-36. PubMed ID: 24732951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of specific interactions of Lp-PLA2 with HDL revealed by hydrogen deuterium exchange mass spectrometry.
    Cao J; Hsu YH; Li S; Woods VL; Dennis EA
    J Lipid Res; 2013 Jan; 54(1):127-33. PubMed ID: 23089916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consensus panel recommendation for incorporating lipoprotein-associated phospholipase A2 testing into cardiovascular disease risk assessment guidelines.
    Davidson MH; Corson MA; Alberts MJ; Anderson JL; Gorelick PB; Jones PH; Lerman A; McConnell JP; Weintraub HS
    Am J Cardiol; 2008 Jun; 101(12A):51F-57F. PubMed ID: 18549872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Lp-PLA(2) mass and apoB-lipoproteins that carry Lp-PLA(2) decrease after sodium.
    Constantinides A; Kerstens MN; Dikkeschei BD; van Pelt LJ; Tellis CC; Tselepis AD; Dullaart RP
    Eur J Clin Invest; 2012 Nov; 42(11):1235-43. PubMed ID: 22957745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma lipoprotein-associated phospholipase A2 is inversely correlated with proprotein convertase subtilisin-kexin type 9.
    Constantinides A; Kappelle PJ; Lambert G; Dullaart RP
    Arch Med Res; 2012 Jan; 43(1):11-4. PubMed ID: 22300679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
    Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
    Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.